about
Characterization and chromosomal localization of the human insulin-like growth factor-binding protein 6 geneDirect activation of glucose transport in primary human myotubes after activation of peroxisome proliferator-activated receptor deltaContiguous localization of the genes encoding human insulin-like growth factor binding proteins 1 (IGBP1) and 3 (IGBP3) on chromosome 7The gene for insulin-like growth factor-binding protein-1 is localized to human chromosomal region 7p14-p12Structure and localization of the human insulin-like growth factor-binding protein 2 geneCharacterization of the chromosomal gene and promoter for human insulin-like growth factor binding protein-5The minor allele of the missense polymorphism Ser251Pro in perilipin 2 (PLIN2) disrupts an α-helix, affects lipolysis, and is associated with reduced plasma triglyceride concentration in humansCharacterization of the human peroxisome proliferator activated receptor delta gene and its expression.Alternative splicing of human peroxisome proliferator-activated receptor delta (PPAR delta): effects on translation efficiency and trans-activation ability.Mutation of conserved cysteines in the Ly6 domain of GPIHBP1 in familial chylomicronemia.Childhood-onset chylomicronaemia with reduced plasma lipoprotein lipase activity and mass: identification of a novel GPIHBP1 mutation.PPARdelta in humans: genetic and pharmacological evidence for a significant metabolic function.Genetic variation in SULF2 is associated with postprandial clearance of triglyceride-rich remnant particles and triglyceride levels in healthy subjectsAllele-specific regulation of MTTP expression influences the risk of ischemic heart disease.Regulation of skeletal muscle physiology and metabolism by peroxisome proliferator-activated receptor delta.Peroxisome proliferator-activated receptor delta and cardiovascular disease.PPARalpha regulates the hepatotoxic biomarker alanine aminotransferase (ALT1) gene expression in human hepatocytes.Two common functional polymorphisms in the promoter region of the coagulation factor VII gene determining plasma factor VII activity and mass concentration.A single Ser259Arg mutation in the gene for lipoprotein lipase causes chylomicronemia in Moroccans of Berber ancestry.Inactivation of lipoprotein lipase occurs on the surface of THP-1 macrophages where oligomers of angiopoietin-like protein 4 are formed.Effects of prolonged exercise on left ventricular mechanical synchrony in long-distance runners: importance of previous exposure to endurance races.Stereotyping at the undergraduate level revealed during interprofessional learning between future doctors and biomedical scientists.PPARdelta increases expression of the human apolipoprotein A-II gene in human liver cells.Open-ended assignments and student responsibility.Promoter analysis of the murine squalene epoxidase gene. Identification of a 205 bp homing region regulated by both SREBP'S and NF-Y.Activation of peroxisome proliferator-activated receptor delta stimulates the proliferation of human breast and prostate cancer cell lines.MicroRNA-9 regulates the expression of peroxisome proliferator-activated receptor δ in human monocytes during the inflammatory response.Efficient adenovirus-mediated ectopic gene expression of human lipoprotein lipase in human hepatic (HepG2) cells.Comparison of insulin-like growth factors and their binding proteins in glioblastoma and neuroblastoma cells.Conservation of IGFBP structure during evolution: cloning of chicken insulin-like growth factor binding protein-5.An ex vivo RT-qPCR-based assay for human peripheral leukocyte responsiveness to glucocorticoids in surgically induced inflammation.A PPAR response element regulates transcription of the gene for human adipose differentiation-related protein.Effects of rosiglitazone on gene expression in subcutaneous adipose tissue in highly active antiretroviral therapy-associated lipodystrophy.Variants of the microsomal triglyceride transfer protein gene are associated with plasma cholesterol levels and body mass index.Expression of adipogenic transcription factors, peroxisome proliferator-activated receptor gamma co-activator 1, IL-6 and CD45 in subcutaneous adipose tissue in lipodystrophy associated with highly active antiretroviral therapy.Regulation of plasma PAI-1 concentrations in HAART-associated lipodystrophy during rosiglitazone therapy.Evidence that peroxisome proliferator-activated receptor delta influences cholesterol metabolism in men.Troglitazone stimulates IGF-binding protein-1 by a PPAR gamma-independent mechanism.Insulin action in cultured human skeletal muscle cells during differentiation: assessment of cell surface GLUT4 and GLUT1 content.Peroxisome proliferator activated receptor delta genotype in relation to cardiovascular risk factors and risk of coronary heart disease in hypercholesterolaemic men.
P50
Q22009079-1E5C29A8-46FF-4EDB-A2B5-615EBFF27FA9Q24298972-AACCEED7-BD60-4CB6-8CF3-51FEE2E43EEDQ28186365-E0ACF916-D9FA-4E4B-900D-56347F08768EQ28258526-BB994797-EB00-4F54-A490-330131DD086DQ28273698-D90302F8-6728-48EB-B827-46F49B40C17AQ28285839-063B42ED-E7A1-44A1-8E05-AF823A61E610Q28289312-98E93ABC-6A61-4093-877C-6B2DD9F440F9Q30878659-31900DBC-8786-4B39-9D5A-CD18E5BE967FQ33294481-B86BA10B-D3BC-4F91-8013-8F97426B93CAQ34089350-BADB5007-821E-40CA-A9D6-3ED497BFB89AQ34164025-260C5C4F-25F7-4413-9FFB-4CB4F9D1B1A1Q34985830-2D0C5B89-28A7-4B6E-913E-E1E62C42BE75Q35053168-844C2258-FAC1-42E4-AED6-07FD47A7A104Q37463241-78F1C7B5-AF1F-431F-BA51-D0DBC305E24DQ37608799-A1FA8BB7-AA22-4C4A-B87B-6908D54DAD46Q38152503-B7051632-1112-4B77-BA47-224C269C283CQ38291295-E83DA3AA-5A21-4D9F-A2BC-A0D629364365Q38324973-D8D2EF06-57C1-42EA-9774-931D8E8BFEB2Q39009398-953D9CD2-05B8-4319-84AE-E996DFC4B984Q39310577-38DF4B66-8387-4A69-B1B4-A8F2BC23C1E9Q39850079-957A0BF7-E46F-4371-A8F0-A6ABDEADE298Q39920422-FD647949-3554-42DD-B08D-3FAF5428D597Q39978180-89339BF6-627E-48A6-81A8-DC62185A5E89Q40218649-B39B7603-5945-4CED-9FEE-394ED4036410Q40222698-B67F145A-1A5C-4E2E-A4F8-A79259B6AEB7Q40559153-C25DB41F-36C1-4790-B4F2-974EB268F5AFQ40846943-210E0D7D-0A71-49D3-A611-671722B58C06Q41133652-AA87EABB-3A56-49AE-8A32-E2B185494E60Q41533155-3FC026FE-F8BB-4BB7-A5E4-92C8B1EF65B9Q42639027-FC424DF4-4FD3-4CF0-B586-0CDD37706730Q42775761-364DE4AF-FCE6-4A1A-8E54-7B82A0D59F1CQ43464576-66406038-2E11-47EC-8F50-9DAC6E75DEAFQ43696251-8F8A002B-551C-4FDA-AE2B-F832281A8AB3Q43855756-AC96087B-5E3C-4EAA-89D1-F977BEA403BCQ44105513-19E7763C-9416-4C9F-B038-A392849B1873Q44342147-34B2DF87-11E8-47D1-ADD6-50D1CBF0DA00Q44342167-2B317777-0D97-4263-B8F4-6165A3C49F0BQ44378409-D1AD2301-28F3-4261-B5C6-6545346A06C5Q44491912-B379BA0F-5FA8-4A14-BF9F-1C08C9192FCBQ44671129-DC5C5CB4-61EA-4950-B86C-4A765A5D4712
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Ewa Ehrenborg
@ast
Ewa Ehrenborg
@en
Ewa Ehrenborg
@es
Ewa Ehrenborg
@nl
Ewa Ehrenborg
@sl
type
label
Ewa Ehrenborg
@ast
Ewa Ehrenborg
@en
Ewa Ehrenborg
@es
Ewa Ehrenborg
@nl
Ewa Ehrenborg
@sl
prefLabel
Ewa Ehrenborg
@ast
Ewa Ehrenborg
@en
Ewa Ehrenborg
@es
Ewa Ehrenborg
@nl
Ewa Ehrenborg
@sl
P106
P21
P31
P496
0000-0003-1993-2468